Description
This product utilizes CD8+ T cells that have been engineered with our proprietary GeneCircuit technology to specifically target CD22 ( clone IW1R22-22). We employs the pUC (pL-RFP-PAX-XbaI) vector components and the SynExpress system of the DNA methylation sites Knock-in/Delayed feedback for a robust and sustained response against cancers.
Host
Human
Target
CD22
Clone
IW1R22-22
Species Reactivity
Human
Cell Source
Modified CD8+ T cells
Sensor Gene
RFP
Promoter
pL
Effector Gene
PAX
Insertion Sites
XbaI
Gene Modification
Knock-in
Modification Domain
DNA methylation sites
Carrier Type
pUC
Transformation Accuracy
0.94
Cell Culture
Plate Culture

For Research Use Only | Not For Clinical Use

Online Inquiry
Related Products
Copyright © 2025 Creative Biolabs. All Rights Reserved.
ISO 9001 Certified - Creative Biolabs Quality Management System.